Congress Park Capital LLC Cytom X Therapeutics, Inc. Put Options Transaction History
Congress Park Capital LLC
- $282 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CTMX
# of Institutions
69Shares Held
54.8MCall Options Held
8.9KPut Options Held
47.9K-
Vanguard Group Inc Valley Forge, PA9.38MShares$17.4 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA6.72MShares$12.5 Million0.28% of portfolio
-
Franklin Resources Inc San Mateo, CA5.77MShares$10.7 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$9.72 Million0.15% of portfolio
-
Prosight Management, LP Dallas, TX3.93MShares$7.31 Million0.9% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $123M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...